AVENUE SOLUTIONS for MERCK & CO. INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to H.R. 5376, Inflation Reduction Act of 2022 (now PL 117-169) and implementation; Issues related to the Continuing Resolution, H.R. 6833; Antibiotics/stewardship; Value of prescription drugs; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); S. 2076/H.R. 3932, PASTEUR Act of 2021; ACIP recommendations related to pneumococcal vaccines; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to reauthorization of FDA user fee bills (H.R.7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 2706/H.R. 5030, DIVERSE Trials Act; Issues related to the FY 2023 Presidents Budget; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Medicare/Medicaid MMM
Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); S.2076/H.R.3932, PASTEUR Act of 2021; Value of prescription drugs; Issues related to Medicare Parts B and D
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.